<DOC>
	<DOCNO>NCT01264107</DOCNO>
	<brief_summary>An Open Study Evaluate Sustained Effect Patients Showing Virological Responses With Muscle-related Symptom Chronic Hepatitis B Patients Who Received Clevudine .</brief_summary>
	<brief_title>An Open Study Evaluate Sustained Effect Patients Showing Virological Responses With Muscle-related Symptom Chronic Hepatitis B Patients Who Received Clevudine</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Clevudine</mesh_term>
	<criteria>1 . Patients currently clevudine treatment . 2 . Patients HBV DNA ï¼œ 300 cpoies/mL ALT normal Showing Musclerelated Symptom Who receive Clevudine 3 . Patient able give write informed consent prior study start comply study requirement . 1 . Patient currently receive antiviral , immunomodulatory , cytotoxic corticosteroid therapy . 2 . Patient pregnant breastfeeding . 3 . Patient significant gastrointestinal , renal , decompensated liver , bronchopulmonary , neurological , cardiac , oncologic ( except HCC ) allergic disease . 4 . Patient , opinion investigator , unsuitable study . 5 . Showing Musclerelated Symptom evidence .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>